Suppr超能文献

acpA 和 acpB 在炭疽芽孢杆菌荚膜积累和兔毒素非依赖性致病性中的作用。

Role of acpA and acpB in Bacillus anthracis capsule accumulation and toxin independent pathogenicity in rabbits.

机构信息

Department of Infectious Diseases, Israel Institute for Biological Research, P.O. Box 19, Ness Ziona 74100, Israel.

Department of Infectious Diseases, Israel Institute for Biological Research, P.O. Box 19, Ness Ziona 74100, Israel.

出版信息

Microb Pathog. 2021 Jun;155:104904. doi: 10.1016/j.micpath.2021.104904. Epub 2021 Apr 28.

Abstract

The poly- δ- d-glutamic acid capsule of Bacillus anthracis plays a major role in this bacterium pathogenicity. Capsule synthesis relies on a 5 gene operon; capB, C, A, D and E that are regulated by acpA and acpB, that respond to the major virulence regulator - atxA. We took a genetic approach to examine the involvement of acpA and acpB in capsule production in vitro and on B. anthracis virulence in vivo. To complement the effect of the mutations on capsule accumulation in vitro, we applied our toxin independent systemic infection method to study their effects in vivo. We found that though the roles of acpA and axpB are redundant in vitro, deleting acpA had a significant effect on pathogenicity, mainly on the time to death. As expected, deletion of both acpA and acpB resulted in loss of capsule accumulation in vitro and full attenuation in vivo, indicating that capsule production depends exclusively on acpA/B regulation. To identify additional effects of acpA and acpB on pathogenicity via non-capsule related virulence pathways, we bypassed acpA/B regulation by inserting the pagA promotor upstream to the cap operon, diverting regulation directly to atxA. This resulted in restoration of capsule accumulation in vitro and virulence (in intravenous or subcutaneous inoculation) in vivo. To test for additional pXO2-based genes involved in capsule production, we cloned the pagAcapA-E into the chromosome of VollumΔpXO2, which restored capsule accumulation. These results indicate that of the pXO2 genes, only capA-E and acpA are required for capsule production.

摘要

炭疽杆菌的聚-δ-D-谷氨酸胶囊在该细菌的致病性中起着主要作用。胶囊合成依赖于一个由 5 个基因组成的操纵子;capB、C、A、D 和 E,由 acpA 和 acpB 调节,它们对主要毒力调节剂-atxA 做出反应。我们采用遗传方法来研究 acpA 和 acpB 在体外胶囊产生和炭疽杆菌体内毒力中的作用。为了补充突变对体外胶囊积累的影响,我们应用我们的毒素独立全身感染方法来研究它们在体内的作用。我们发现,尽管 acpA 和 axpB 在体外的作用是冗余的,但删除 acpA 对致病性有显著影响,主要是对死亡时间的影响。正如预期的那样,删除 acpA 和 acpB 导致体外胶囊积累的丧失和体内完全衰减,表明胶囊的产生完全依赖于 acpA/B 的调节。为了通过非胶囊相关的毒力途径识别 acpA 和 acpB 对致病性的其他影响,我们通过将 pagA 启动子插入 cap 操纵子的上游绕过 acpA/B 的调节,直接将调节定向到 atxA。这导致体外胶囊积累和体内毒力(静脉内或皮下接种)的恢复。为了测试与胶囊生产有关的其他 pXO2 基因,我们将 pagAcapA-E 克隆到 VollumΔpXO2 的染色体中,这恢复了胶囊的积累。这些结果表明,在 pXO2 基因中,只有 capA-E 和 acpA 是胶囊生产所必需的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验